Specialty drug spending is skyrocketing with no end in sight and almost half of it is billed to the medical rather than the pharmacy benefit. At the same time, the average annual retail cost of a specialty drug now exceeds the median U.S. household wage.
The momentum is undeniable and it is creating pressure on the industry status quo. Change is inevitable, but the key question remains at what speed will change take hold.
In this webinar, PSG experts will illustrate how the drug management industry is poised for a rapid transformation driven by skyrocketing drugs cost. They will address:
- How the drug pipeline could accelerate industry transformation
- The gaps in effective drug management that could be costing plan sponsors millions
- Smart strategies plan sponsors can employ to optimize drug benefits today and tomorrow